Experimental aids vaccine now in production
Wednesday, November 12, 2008 - 15:42
in Health & Medicine
(PhysOrg.com) -- The advance towards a vaccine for HIV/AIDS has taken another step closer to realization. A vaccine, developed by Dr. Chil-Yong Kang and his team at the Schulich School of Medicine & Dentistry at The University of Western Ontario, and licensed to Sumagen Canada Inc., has now been manufactured for use in trials - first, in toxicology trials using animal models and then in Phase 1 human clinical trials. The vaccine has been manufactured at a bio-safety level 3 (BSL3) good manufacturing practice (GMP) facility in the United States.
Read the whole article on Physorg
More from Physorg
Related
- India continues to progress in AIDS vaccine development effortsMon, 18 Aug 2008, 0:22:02 EDT
- TB vaccine developed at McMaster University in CanadaThu, 19 Mar 2009, 16:53:09 EDT
- Early results from clinical trials of 2009 H1N1 influenza vaccines in healthy adultsFri, 11 Sep 2009, 13:39:48 EDT
- Promising trials of malaria vaccine lead to calls for Phase 3 developmentMon, 8 Dec 2008, 12:32:14 EST
- How HIV vaccine might have increased odds of infectionMon, 3 Nov 2008, 10:50:24 EST